Literature DB >> 23039391

Hypnic headache and caffeine.

Dagny Holle1, Mark Obermann.   

Abstract

Hypnic headache (HH) is a rare primary headache disorder primarily affecting patients over the age of 50 years. This headache entity occurs exclusively at night almost always at the same time. Imaging data as well as the strict circadian rhythm of headache attacks suggest a hypothalamic involvement in the underlying pathophysiology of this headache disorder. One interesting clinical feature about HH is its therapeutic response to caffeine as an acute as well as prophylactic agent. This review addresses the efficacy of caffeine in HH as well as in other headache disorders, and attempts to give insight into the analgesic properties of this substance. In addition, it depicts possible problems of caffeine consumption with regard to headache.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23039391     DOI: 10.1586/ern.12.100

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  5 in total

Review 1.  Indomethacin-responsive headaches.

Authors:  Juliana VanderPluym
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 2.  Caffeine: What Is Its Role in Pain Medicine?

Authors:  Sri Harsha Boppana; Michael Peterson; Austin L Du; L V Simhachalam Kutikuppala; Rodney A Gabriel
Journal:  Cureus       Date:  2022-06-02

Review 3.  Hypnic headache: a review of 2012 publications.

Authors:  Shatabdi Patel
Journal:  Curr Pain Headache Rep       Date:  2013-07

Review 4.  The Role of Caffeine in Pain Management: A Brief Literature Review.

Authors:  Alireza Baratloo; Alaleh Rouhipour; Mohammad Mehdi Forouzanfar; Saeed Safari; Marzieh Amiri; Ahmed Negida
Journal:  Anesth Pain Med       Date:  2016-03-26

Review 5.  Caffeine and Primary (Migraine) Headaches-Friend or Foe?

Authors:  Karl B Alstadhaug; Anna P Andreou
Journal:  Front Neurol       Date:  2019-12-03       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.